Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Arcutis Biotherapeutics (ARQT) over the last 7 years, with Dec 2024 value amounting to $28.8 million.

  • Arcutis Biotherapeutics' Cash from Investing Activities fell 129.78% to -$25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.8 million, marking a year-over-year increase of 156.86%. This contributed to the annual value of $28.8 million for FY2024, which is 84.01% down from last year.
  • Arcutis Biotherapeutics' Cash from Investing Activities amounted to $28.8 million in FY2024, which was down 84.01% from $180.2 million recorded in FY2023.
  • In the past 5 years, Arcutis Biotherapeutics' Cash from Investing Activities ranged from a high of $180.2 million in FY2023 and a low of -$181.8 million during FY2020.
  • Moreover, its 3-year median value for Cash from Investing Activities was $28.8 million (2024), whereas its average is $40.6 million.
  • Per our database at Business Quant, Arcutis Biotherapeutics' Cash from Investing Activities tumbled by 590.69% in 2020 and then spiked by 306.69% in 2023.
  • Arcutis Biotherapeutics' Cash from Investing Activities (Yearly) stood at -$181.8 million in 2020, then skyrocketed by 58.23% to -$76.0 million in 2021, then fell by 14.81% to -$87.2 million in 2022, then surged by 306.69% to $180.2 million in 2023, then tumbled by 84.01% to $28.8 million in 2024.